Global Bioconjugation 麻豆原创 Research Report 2024

Publication ID:

PB511243051

Publication Date:

November 4, 2024

Pages:

106

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

Bioconjugation refers to the process of chemically linking two biomolecules, such as proteins, peptides, nucleic acids, or small molecules, to create a hybrid molecule with enhanced properties or functions. This technique is widely used in fields like drug development, diagnostics, and biotechnology, as it allows for targeted delivery of therapeutics, improves stability, and enhances the efficacy of drugs. Common bioconjugation methods include the use of click chemistry, crosslinking agents, and site-specific conjugation techniques, which enable precise control over the structure and functionality of the resulting conjugate.
The global Bioconjugation market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Bioconjugation is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Bioconjugation is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Bioconjugation include Danaher, Lonza, Thermo Fisher Scientific, Merck, AbbVie, Sartorius, Bio-Rad Laboratories, Catalent, BD, Agilent, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Bioconjugation, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bioconjugation.
The Bioconjugation market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Bioconjugation market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bioconjugation manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Danaher
Lonza
Thermo Fisher Scientific
Merck
AbbVie
Sartorius
Bio-Rad Laboratories
Catalent
BD
Agilent
Promega
Roche
Charles River Laboratories
Genscript Biotech
Piramal Pharma
WuXi Biologics
Segment by Type
Chemical Conjugation
Click Chemistry
Enzyme-mediated Conjugatio
Others
Segment by Application
Pharmaceutical
Research Institutes
Hosptial
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Bioconjugation manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Bioconjugation in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Bioconjugation 麻豆原创 Overview
1.1 Product Definition
1.2 Bioconjugation by Type
1.2.1 Global Bioconjugation 麻豆原创 Value Comparison by Type (2024-2030)
1.2.2 Chemical Conjugation
1.2.3 Click Chemistry
1.2.4 Enzyme-mediated Conjugatio
1.2.5 Others
1.3 Bioconjugation by Application
1.3.1 Global Bioconjugation 麻豆原创 Value by Application (2024-2030)
1.3.2 Pharmaceutical
1.3.3 Research Institutes
1.3.4 Hosptial
1.3.5 Others
1.4 Global Bioconjugation 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Bioconjugation Revenue 2019-2030
1.4.2 Global Bioconjugation Sales 2019-2030
1.4.3 Global Bioconjugation 麻豆原创 Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Bioconjugation 麻豆原创 Competition by Manufacturers
2.1 Global Bioconjugation Sales 麻豆原创 Share by Manufacturers (2019-2024)
2.2 Global Bioconjugation Revenue 麻豆原创 Share by Manufacturers (2019-2024)
2.3 Global Bioconjugation Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Bioconjugation, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Bioconjugation, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Bioconjugation, Product Type & Application
2.7 Global Key Manufacturers of Bioconjugation, Date of Enter into This Industry
2.8 Global Bioconjugation 麻豆原创 Competitive Situation and Trends
2.8.1 Global Bioconjugation 麻豆原创 Concentration Rate
2.8.2 The Global 5 and 10 Largest Bioconjugation Players 麻豆原创 Share by Revenue
2.8.3 Global Bioconjugation 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Bioconjugation 麻豆原创 Scenario by Region
3.1 Global Bioconjugation 麻豆原创 Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Bioconjugation Sales by Region: 2019-2030
3.2.1 Global Bioconjugation Sales by Region: 2019-2024
3.2.2 Global Bioconjugation Sales by Region: 2025-2030
3.3 Global Bioconjugation Revenue by Region: 2019-2030
3.3.1 Global Bioconjugation Revenue by Region: 2019-2024
3.3.2 Global Bioconjugation Revenue by Region: 2025-2030
3.4 North America Bioconjugation 麻豆原创 Facts & Figures by Country
3.4.1 North America Bioconjugation 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Bioconjugation Sales by Country (2019-2030)
3.4.3 North America Bioconjugation Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Bioconjugation 麻豆原创 Facts & Figures by Country
3.5.1 Europe Bioconjugation 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Bioconjugation Sales by Country (2019-2030)
3.5.3 Europe Bioconjugation Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Bioconjugation 麻豆原创 Facts & Figures by Region
3.6.1 Asia Pacific Bioconjugation 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Bioconjugation Sales by Region (2019-2030)
3.6.3 Asia Pacific Bioconjugation Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Bioconjugation 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Bioconjugation 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Bioconjugation Sales by Country (2019-2030)
3.7.3 Latin America Bioconjugation Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Bioconjugation 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Bioconjugation 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Bioconjugation Sales by Country (2019-2030)
3.8.3 Middle East and Africa Bioconjugation Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Bioconjugation Sales by Type (2019-2030)
4.1.1 Global Bioconjugation Sales by Type (2019-2024)
4.1.2 Global Bioconjugation Sales by Type (2025-2030)
4.1.3 Global Bioconjugation Sales 麻豆原创 Share by Type (2019-2030)
4.2 Global Bioconjugation Revenue by Type (2019-2030)
4.2.1 Global Bioconjugation Revenue by Type (2019-2024)
4.2.2 Global Bioconjugation Revenue by Type (2025-2030)
4.2.3 Global Bioconjugation Revenue 麻豆原创 Share by Type (2019-2030)
4.3 Global Bioconjugation Price by Type (2019-2030)
5 Segment by Application
5.1 Global Bioconjugation Sales by Application (2019-2030)
5.1.1 Global Bioconjugation Sales by Application (2019-2024)
5.1.2 Global Bioconjugation Sales by Application (2025-2030)
5.1.3 Global Bioconjugation Sales 麻豆原创 Share by Application (2019-2030)
5.2 Global Bioconjugation Revenue by Application (2019-2030)
5.2.1 Global Bioconjugation Revenue by Application (2019-2024)
5.2.2 Global Bioconjugation Revenue by Application (2025-2030)
5.2.3 Global Bioconjugation Revenue 麻豆原创 Share by Application (2019-2030)
5.3 Global Bioconjugation Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Danaher
6.1.1 Danaher Company Information
6.1.2 Danaher Description and Business Overview
6.1.3 Danaher Bioconjugation Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Danaher Bioconjugation Product Portfolio
6.1.5 Danaher Recent Developments/Updates
6.2 Lonza
6.2.1 Lonza Company Information
6.2.2 Lonza Description and Business Overview
6.2.3 Lonza Bioconjugation Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Lonza Bioconjugation Product Portfolio
6.2.5 Lonza Recent Developments/Updates
6.3 Thermo Fisher Scientific
6.3.1 Thermo Fisher Scientific Company Information
6.3.2 Thermo Fisher Scientific Description and Business Overview
6.3.3 Thermo Fisher Scientific Bioconjugation Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Thermo Fisher Scientific Bioconjugation Product Portfolio
6.3.5 Thermo Fisher Scientific Recent Developments/Updates
6.4 Merck
6.4.1 Merck Company Information
6.4.2 Merck Description and Business Overview
6.4.3 Merck Bioconjugation Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Merck Bioconjugation Product Portfolio
6.4.5 Merck Recent Developments/Updates
6.5 AbbVie
6.5.1 AbbVie Company Information
6.5.2 AbbVie Description and Business Overview
6.5.3 AbbVie Bioconjugation Sales, Revenue and Gross Margin (2019-2024)
6.5.4 AbbVie Bioconjugation Product Portfolio
6.5.5 AbbVie Recent Developments/Updates
6.6 Sartorius
6.6.1 Sartorius Company Information
6.6.2 Sartorius Description and Business Overview
6.6.3 Sartorius Bioconjugation Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Sartorius Bioconjugation Product Portfolio
6.6.5 Sartorius Recent Developments/Updates
6.7 Bio-Rad Laboratories
6.7.1 Bio-Rad Laboratories Company Information
6.7.2 Bio-Rad Laboratories Description and Business Overview
6.7.3 Bio-Rad Laboratories Bioconjugation Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Bio-Rad Laboratories Bioconjugation Product Portfolio
6.7.5 Bio-Rad Laboratories Recent Developments/Updates
6.8 Catalent
6.8.1 Catalent Company Information
6.8.2 Catalent Description and Business Overview
6.8.3 Catalent Bioconjugation Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Catalent Bioconjugation Product Portfolio
6.8.5 Catalent Recent Developments/Updates
6.9 BD
6.9.1 BD Company Information
6.9.2 BD Description and Business Overview
6.9.3 BD Bioconjugation Sales, Revenue and Gross Margin (2019-2024)
6.9.4 BD Bioconjugation Product Portfolio
6.9.5 BD Recent Developments/Updates
6.10 Agilent
6.10.1 Agilent Company Information
6.10.2 Agilent Description and Business Overview
6.10.3 Agilent Bioconjugation Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Agilent Bioconjugation Product Portfolio
6.10.5 Agilent Recent Developments/Updates
6.11 Promega
6.11.1 Promega Company Information
6.11.2 Promega Description and Business Overview
6.11.3 Promega Bioconjugation Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Promega Bioconjugation Product Portfolio
6.11.5 Promega Recent Developments/Updates
6.12 Roche
6.12.1 Roche Company Information
6.12.2 Roche Description and Business Overview
6.12.3 Roche Bioconjugation Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Roche Bioconjugation Product Portfolio
6.12.5 Roche Recent Developments/Updates
6.13 Charles River Laboratories
6.13.1 Charles River Laboratories Company Information
6.13.2 Charles River Laboratories Description and Business Overview
6.13.3 Charles River Laboratories Bioconjugation Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Charles River Laboratories Bioconjugation Product Portfolio
6.13.5 Charles River Laboratories Recent Developments/Updates
6.14 Genscript Biotech
6.14.1 Genscript Biotech Company Information
6.14.2 Genscript Biotech Description and Business Overview
6.14.3 Genscript Biotech Bioconjugation Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Genscript Biotech Bioconjugation Product Portfolio
6.14.5 Genscript Biotech Recent Developments/Updates
6.15 Piramal Pharma
6.15.1 Piramal Pharma Company Information
6.15.2 Piramal Pharma Description and Business Overview
6.15.3 Piramal Pharma Bioconjugation Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Piramal Pharma Bioconjugation Product Portfolio
6.15.5 Piramal Pharma Recent Developments/Updates
6.16 WuXi Biologics
6.16.1 WuXi Biologics Company Information
6.16.2 WuXi Biologics Description and Business Overview
6.16.3 WuXi Biologics Bioconjugation Sales, Revenue and Gross Margin (2019-2024)
6.16.4 WuXi Biologics Bioconjugation Product Portfolio
6.16.5 WuXi Biologics Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Bioconjugation Industry Chain Analysis
7.2 Bioconjugation Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Bioconjugation Production Mode & Process
7.4 Bioconjugation Sales and 麻豆原创ing
7.4.1 Bioconjugation Sales Channels
7.4.2 Bioconjugation Distributors
7.5 Bioconjugation Customers
8 Bioconjugation 麻豆原创 Dynamics
8.1 Bioconjugation Industry Trends
8.2 Bioconjugation 麻豆原创 Drivers
8.3 Bioconjugation 麻豆原创 Challenges
8.4 Bioconjugation 麻豆原创 Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Danaher
Lonza
Thermo Fisher Scientific
Merck
AbbVie
Sartorius
Bio-Rad Laboratories
Catalent
BD
Agilent
Promega
Roche
Charles River Laboratories
Genscript Biotech
Piramal Pharma
WuXi Biologics

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.